- Home
- PETS vs SRTS Comparison
PETS vs SRTS Comparison
Compare PETS & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETS
- SRTS
- Stock Information
- Founded
- PETS 1996
- SRTS 2010
- Country
- PETS United States
- SRTS United States
- Employees
- PETS N/A
- SRTS N/A
- Industry
- PETS Retail-Drug Stores and Proprietary Stores
- SRTS Medical/Dental Instruments
- Sector
- PETS Consumer Staples
- SRTS Health Care
- Exchange
- PETS Nasdaq
- SRTS Nasdaq
- Market Cap
- PETS 58.9M
- SRTS 51.8M
- IPO Year
- PETS N/A
- SRTS 2016
- Fundamental
- Price
- PETS $2.80
- SRTS $3.15
- Analyst Decision
- PETS Sell
- SRTS Strong Buy
- Analyst Count
- PETS 1
- SRTS 3
- Target Price
- PETS $3.20
- SRTS $8.00
- AVG Volume (30 Days)
- PETS 93.7K
- SRTS 84.7K
- Earning Date
- PETS 11-05-2025
- SRTS 11-13-2025
- Dividend Yield
- PETS N/A
- SRTS N/A
- EPS Growth
- PETS N/A
- SRTS N/A
- EPS
- PETS 0.02
- SRTS N/A
- Revenue
- PETS $247,010,000.00
- SRTS $37,564,000.00
- Revenue This Year
- PETS N/A
- SRTS N/A
- Revenue Next Year
- PETS N/A
- SRTS $46.14
- P/E Ratio
- PETS $164.09
- SRTS N/A
- Revenue Growth
- PETS N/A
- SRTS 3.29
- 52 Week Low
- PETS $2.72
- SRTS $3.03
- 52 Week High
- PETS $6.85
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- PETS 38.49
- SRTS 37.43
- Support Level
- PETS $2.98
- SRTS $3.09
- Resistance Level
- PETS $2.90
- SRTS $3.29
- Average True Range (ATR)
- PETS 0.11
- SRTS 0.11
- MACD
- PETS -0.01
- SRTS 0.04
- Stochastic Oscillator
- PETS 18.60
- SRTS 15.38
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.